Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tyrosine Kinase Inhibitors Ameliorate Autoimmune Encephalomyelitis in a Mouse Model of Multiple Sclerosis
Oliver Crespo, Stacey Kang, Richard Daneman, et al.
Journal of Clinical Immunology (2011) Vol. 31, Iss. 6, pp. 1010-1020
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Regulation of Microglial Proliferation during Chronic Neurodegeneration
Diego Gómez‐Nicola, Nina L. Fransen, Stefano Suzzi, et al.
Journal of Neuroscience (2013) Vol. 33, Iss. 6, pp. 2481-2493
Open Access | Times Cited: 378
Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System
Violeta Chiţu, Şölen Gökhan, Sayan Nandi, et al.
Trends in Neurosciences (2016) Vol. 39, Iss. 6, pp. 378-393
Open Access | Times Cited: 290
Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges
Jinming Han, Violeta Chiţu, E. Richard Stanley, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 4
Open Access | Times Cited: 98
An updated assessment of microglia depletion: current concepts and future directions
Jinming Han, Robert A. Harris, Xing‐Mei Zhang
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 131
Genetic targeting of microglia
Peter Wieghofer, Klaus‐Peter Knobeloch, Marco Prinz
Glia (2014) Vol. 63, Iss. 1, pp. 1-22
Closed Access | Times Cited: 116
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study
Paolo Fraticelli, Barbara Gabrielli, Giovanni Pomponio, et al.
Arthritis Research & Therapy (2014) Vol. 16, Iss. 4, pp. R144-R144
Open Access | Times Cited: 105
CSF1R Inhibition Reduces Microglia Proliferation, Promotes Tissue Preservation and Improves Motor Recovery After Spinal Cord Injury
Yannick Nicolas Gerber, Guillaume Saint-Martin, Claire M. Bringuier, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 96
Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer
Chunmei Piao, Wenmei Zhang, Taotao Li, et al.
Experimental Cell Research (2018) Vol. 366, Iss. 2, pp. 127-138
Closed Access | Times Cited: 80
Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages
Martina Di Nunzio, Rossella Di Sapia, Diletta Sorrentino, et al.
Epilepsia (2021) Vol. 62, Iss. 8, pp. 1931-1945
Closed Access | Times Cited: 46
Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates
Gaëtan Poulen, Emilie Aloy, Claire M. Bringuier, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 8640-8659
Open Access | Times Cited: 45
IL-34 and CSF-1, deciphering similarities and differences at steady state and in diseases
Antoine Freuchet, Apolline Salama, Séverine Remy, et al.
Journal of Leukocyte Biology (2021) Vol. 110, Iss. 4, pp. 771-796
Closed Access | Times Cited: 41
Bruton’s Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis Therapy
Antonio García‐Merino
Cells (2021) Vol. 10, Iss. 10, pp. 2560-2560
Open Access | Times Cited: 41
Tec Family Kinases in Inflammation and Disease
Nicole J. Horwood, Ania M. Urbaniak, Lynett Danks
International Reviews of Immunology (2012) Vol. 31, Iss. 2, pp. 87-103
Closed Access | Times Cited: 68
Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis
Nozha Borjini, Mercedes Fernández, Luciana Giardino, et al.
Journal of Neuroinflammation (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
Milena Z. Adzemovic, Manuel Zeitelhofer, Ulf Eriksson, et al.
PLoS ONE (2013) Vol. 8, Iss. 2, pp. e56586-e56586
Open Access | Times Cited: 58
Mast Cells and Innate Lymphoid Cells: Underappreciated Players in CNS Autoimmune Demyelinating Disease
Melissa A. Brown, R WEINBERG
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 47
Bruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis
Edgar Carnero Contentti, Jorge Correale
Expert Opinion on Emerging Drugs (2020) Vol. 25, Iss. 4, pp. 377-381
Open Access | Times Cited: 42
Bruton’s Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis
Neeta Garg, Elizabeth Jordan Padron, Kottil Rammohan, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 6139-6139
Open Access | Times Cited: 27
Selective proliferative response of microglia to alternative polarization signals
Giovanna Pepe, Marcella De Maglie, Lucia Minoli, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord
Manish Kumar, Ritu Kulshrestha, Nirmal Singh, et al.
Pharmacological Research (2019) Vol. 143, pp. 86-96
Closed Access | Times Cited: 37
Pharmacological Inhibition of Microglial Proliferation Supports Blood–Brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis
Nozha Borjini, Mercedes Fernández, Luciana Giardino, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 414-414
Open Access
Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Iwona Gągało, Izabela Rusiecka, Ivan Kocić
Current Neuropharmacology (2015) Vol. 13, Iss. 6, pp. 836-844
Open Access | Times Cited: 38
Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis
Sebastiano Giuseppe Crisafulli, Simona Brajkovic, Maria Sara Cipolat Mis, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 4, pp. 2789-2813
Closed Access | Times Cited: 37
Microglial modulation through colony‐stimulating factor‐1 receptor inhibition attenuates demyelination
Victoria Sofía Berenice Wies Mancini, Juana M. Pasquini, Jorge Correale, et al.
Glia (2018) Vol. 67, Iss. 2, pp. 291-308
Closed Access | Times Cited: 37
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
Austin Lui, Jordan Vanleuven, David Perekopskiy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1546-1546
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top